Ono Pharmaceutical Co., Ltd. is a leading global healthcare company committed to delivering new, innovative pharmaceutical products to patients and championing the fight against disease and pain. Ono Pharmaceutical carries out these goals in cooperation with researchers, patients, their families, and healthcare providers.
The Ono Pharma Foundation was established to support academic research in relevant scientific fields, which have the potential of making significant impact on therapeutic approaches to disease. The Foundation’s competitive awards program, the Ono Pharma Breakthrough Science Initiative Awards Program (“Ono Initiative”), is the embodiment of the Foundation’s commitment to focus on and accelerate researcher-driven open innovation by supporting high-risk and high-reward science research projects which have potential to lead to science discoveries/solutions and, possibly, based on further research, to breakthrough treatments for patients.
Although additional areas of research may be added in future years, in 2023 the Ono Pharma Foundation will only consider proposals for scientific research projects addressing Chemical Biology Research.
Each Nominating Institution may nominate up to two (2) applicants in Chemical Biology Research.
Potential applicants should consult with Steve Murray, Foundation Relations (firstname.lastname@example.org) before applying.
- Duke Internal: Dec. 15, 2022
- Required Letter of Intent: Feb. 15, 2023
- Invited Proposal due date: May 17, 2023